276 related articles for article (PubMed ID: 12036938)
1. Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells.
Huang JJ; Lin MC; Bai YX; Jing DD; Wong BC; Han SW; Lin J; Xu B; Huang CF; Kung HF
Cancer Res; 2002 Jun; 62(11):3226-32. PubMed ID: 12036938
[TBL] [Abstract][Full Text] [Related]
2. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT.
Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W
Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183
[TBL] [Abstract][Full Text] [Related]
3. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
4. A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide.
Ng SS; Gao Y; Chau DH; Li GH; Lai LH; Huang PT; Huang CF; Huang JJ; Chen YC; Kung HF; Lin MC
Cancer Gene Ther; 2007 Jun; 14(6):561-72. PubMed ID: 17384579
[TBL] [Abstract][Full Text] [Related]
5. Reconstituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts.
Yudoh K; Matsuno H; Nakazawa F; Katayama R; Kimura T
J Bone Miner Res; 2001 Aug; 16(8):1453-64. PubMed ID: 11499868
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.
Biroccio A; Amodei S; Benassi B; Scarsella M; Cianciulli A; Mottolese M; Del Bufalo D; Leonetti C; Zupi G
Oncogene; 2002 May; 21(19):3011-9. PubMed ID: 12082531
[TBL] [Abstract][Full Text] [Related]
7. hTERT associates with human telomeres and enhances genomic stability and DNA repair.
Sharma GG; Gupta A; Wang H; Scherthan H; Dhar S; Gandhi V; Iliakis G; Shay JW; Young CS; Pandita TK
Oncogene; 2003 Jan; 22(1):131-46. PubMed ID: 12527915
[TBL] [Abstract][Full Text] [Related]
8. Long-term suppression of telomerase expression in HeLa cell clones, transfected with an expression vector carrying siRNA targeting hTERT mRNA.
Kurvinen K; Syrjänen S; Johansson B
Int J Oncol; 2006 Jul; 29(1):279-88. PubMed ID: 16773210
[TBL] [Abstract][Full Text] [Related]
9. TERT regulates cell survival independent of telomerase enzymatic activity.
Cao Y; Li H; Deb S; Liu JP
Oncogene; 2002 May; 21(20):3130-8. PubMed ID: 12082628
[TBL] [Abstract][Full Text] [Related]
10. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
[TBL] [Abstract][Full Text] [Related]
12. Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase.
Sun B; Huang Q; Liu S; Chen M; Hawks CL; Wang L; Zhang C; Hornsby PJ
Cancer Res; 2004 Sep; 64(17):6144-51. PubMed ID: 15342398
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of silencing hTERT gene by short hairpin RNA on growth of human laryngeal squamous cell carcinoma xenograft in nude mice].
Liu D; Tao ZZ; Xiao BK; Chen SM; Chi HM
Ai Zheng; 2006 Jan; 25(1):11-6. PubMed ID: 16405742
[TBL] [Abstract][Full Text] [Related]
14. Retroviral-mediated expression of telomerase in normal human cells provides a selective growth advantage.
Forsythe HL; Elmore LW; Jensen KO; Landon MR; Holt SE
Int J Oncol; 2002 Jun; 20(6):1137-43. PubMed ID: 12011990
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth.
Cassar L; Li H; Pinto AR; Nicholls C; Bayne S; Liu JP
Cancer Res; 2008 Nov; 68(22):9157-66. PubMed ID: 19010887
[TBL] [Abstract][Full Text] [Related]
16. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
17. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss.
Ji HJ; Rha SY; Jeung HC; Yang SH; An SW; Chung HC
Breast Cancer Res Treat; 2005 Oct; 93(3):227-36. PubMed ID: 16132531
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human telomerase enhances the effect of the tyrosine kinase inhibitor, imatinib, in BCR-ABL-positive leukemia cells.
Tauchi T; Nakajima A; Sashida G; Shimamoto T; Ohyashiki JH; Abe K; Yamamoto K; Ohyashiki K
Clin Cancer Res; 2002 Nov; 8(11):3341-7. PubMed ID: 12429620
[TBL] [Abstract][Full Text] [Related]
20. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
